title: Clinical and molecular survey in 124 Chinese patients with Leigh or Leigh-like syndrome.
abstract: Leigh syndrome is the most common mitochondrial disorder in children characterized by necrotic lesions in the central nervous system. Both mitochondrial DNA (mtDNA) and nuclear DNA defects in the mitochondrial respiratory chain can lead to this disease. To characterize the clinical and genetic traits of Leigh or Leigh-like syndrome patients in China, 124 unrelated cases were collected between 1992 and 2005. Seventy-seven cases (62.1%) met the typical criteria of Leigh syndrome, including symmetrical bilateral abnormal signals in the basal ganglia, thalamus and brain stem, etc. Other cases (37.9%) belonged to Leigh-like syndrome with atypical clinical or radiological manifestations. Late-onset patients accounted for 20.2%, which is more than previously reported. Movement disorder was the most common symptoms in our patients. Thirty-two patients (25.8%) were confirmed to carry mutant genes. Among them, six cases (4.8%) have been demonstrated to have point mutations in mitochondrial DNA. Two separate patients were detected to have mutations on A8344G and A3243G. The T8993G point mutation was identified in one patient and T8993C in one other patient. SURF1 mutations associated with cytochrome-c oxidase deficiency were identified in 25 patients (20.2%). Four unreported variations have been identified in SURF1 gene from three patients. G604C was found in 22 patients. Only one patient had C214T mutation in the pyruvate dehydrogenase E1alpha subunit gene. In the remaining 92 patients (74.2%), a specific molecular dysfunction or underlying metabolic abnormality could not be identified.
authors.affiliation: Department of Pediatrics, Peking University First Hospital, Beijing, PR China.
authors.forename: Y
authors.initials: Y
authors.lastname: Zhang
authors.forename: Y L
authors.initials: YL
authors.lastname: Yang
authors.forename: F
authors.initials: F
authors.lastname: Sun
authors.forename: X
authors.initials: X
authors.lastname: Cai
authors.forename: N
authors.initials: N
authors.lastname: Qian
authors.forename: Y
authors.initials: Y
authors.lastname: Yuan
authors.forename: Z X
authors.initials: ZX
authors.lastname: Wang
authors.forename: Y
authors.initials: Y
authors.lastname: Qi
authors.forename: J X
authors.initials: JX
authors.lastname: Xiao
authors.forename: X Y
authors.initials: XY
authors.lastname: Wang
authors.forename: Y H
authors.initials: YH
authors.lastname: Zhang
authors.forename: Y W
authors.initials: YW
authors.lastname: Jiang
authors.forename: J
authors.initials: J
authors.lastname: Qin
authors.forename: X R
authors.initials: XR
authors.lastname: Wu
mesh_terms: D000293:Adolescent; D017668:Age of Onset; D044466:Asian People / Q000235:genetics; D001921:Brain / Q000000981:diagnostic imaging / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D030401:Cytochrome-c Oxidase Deficiency / Q000235:genetics; D004272:DNA, Mitochondrial / Q000235:genetics; D005260:Female; D014644:Genetic Variation; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007888:Leigh Disease / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics*; D008279:Magnetic Resonance Imaging; D008297:Male; D008565:Membrane Proteins / Q000235:genetics; D024101:Mitochondrial Proteins / Q000235:genetics; D009069:Movement Disorders / Q000209:etiology; D009154:Mutation; D017354:Point Mutation; D030481:Pyruvate Dehydrogenase (Lipoamide) / Q000235:genetics; D014057:Tomography, X-Ray Computed
chemical_list: D004272:DNA, Mitochondrial; D008565:Membrane Proteins; D024101:Mitochondrial Proteins; C092928:Surf-1 protein; D030481:Pyruvate Dehydrogenase (Lipoamide); C065640:pyruvate dehydrogenase E1alpha subunit